GlobeNewswire
-
Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
08/11/2026 -
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
08/11/2026 -
CIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD
08/11/2026 -
AVITA Medical to Host Investor Webinar Briefing
08/11/2026 -
Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026
08/11/2026 -
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
08/11/2026 -
Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases
08/11/2026 -
argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis
07/11/2026 -
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
07/11/2026 -
Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026
07/11/2026 -
MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results
07/11/2026 -
Confluent Medical Technologies Acquires Northern Nitinol, Expanding Advanced Nitinol Rapid Prototyping Capabilities
06/11/2026 -
Surrozen to Present at Upcoming Healthcare Investor Conference
06/11/2026 -
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06/11/2026 -
Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial Results
06/11/2026 -
Entera Announces Third Quarter 2026 Financial Results and Business Updates
06/11/2026 -
Amwell makes grant to new employees under inducement plan
06/11/2026 -
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026 -
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026
06/11/2026
Pages